Paws for Thought

Watching, always watching

[Brexit Bin 🇪🇺🇬🇧🇩🇪🕊🇺🇦 #BrexitHasFailed @BrexitBin]

The far-right are against measures to combat climate change. They're also against giving sanctuary to refugees. The fact that climate change will create more refugees than ever before is a concept their racist minds are too stupid to compute.
#FarageOut

[Ananda Pharma @AnandaPharma]

New RCT evidence in anorexia nervosa adds to a growing body of clinical signals for high-dose purified CBD. The dosing used sits in the same broad range as Ananda's own Phase I and planned Phase II programmes. From epilepsy to rare heart failure to anorexia, a consistent pattern is emerging: pharmaceutical-grade CBD at the right dose, in properly designed trials, produces measurable effects. That is precisely the thesis underpinning MRX1 and our ENDOCAN-1 and ACTION studies.

https://t.co/jEFgk27Md6

#CBD #MRX #endometriosis #CIPN #clinicaltrials

[Ananda Pharma @AnandaPharma]

Thanks @BofC_Global for the write-up on our recent activity:

✔ A fifth UK patent application filed for our MRX2T CBD+THC oil in preparation for potential further clinical trials

✔ MOU with Nottingham Trent University signed

https://t.co/ed6tTiw1yN

[Ananda Pharma @AnandaPharma]

Ananda has today announced that its subsidiary, MRX Medical, has now launched its first two cannabinoid medicines on the unlicenced medicinal products market.

For more about Ananda and the announcement visit https://t.co/S7a4eVOyAQ or https://t.co/BUhi8hqprY

[Dazler @60Toad60]

Looking for a #uk #medical #cannabis company to #invest in then @AnandaPlc has to be a stand out company that's ticking all the right boxes.

[MAMEDICA® @mamedicauk]

Our CEO Jon Robson joined @SkyNews to explain why a rising number of people are relying on medical cannabis to manage conditions like #ADHD.

With wait times as high as five years, private clinics like Mamedica are here to plug this healthcare gap 🚀 https://t.co/xIkLhWU8tc

[🇬🇧 MedBud® @MedBudUK]

Feedback request, as mentioned in our last big update list we're likely to implement new stock brackets for #MedicalCannabis flower next week; due to ever-increasing demand.

Revising this for the first time, do we need to go even further than the below proposed increases?

[🇬🇧 MedBud® @MedBudUK]

🇬🇧 MRX Medical owned by @AnandaPLC have launched their first oil medications for #MedicalCannabis patients, manufactured by @Rokshaw_Labs.

MRX-1 and MRX-2 are 100/mg CBD products with differing terpene profiles, and trace amounts of THC.

Pricing being confirmed, 30ml bottles.

[Dazler @60Toad60]

Anybody wishing to read an incredible private investor evaluation note on @AnandaPlc then it worth joining our telegram group in order to do so! #uk #medical #cannabis #exciting times!
https://t.co/LNNEMOuCF1

[Ananda Pharma @AnandaPharma]

It is summertime and Ananda's research facility is in full swing. The first photo shows our Apocalypse cultivar flowering with plenty of trichomes as part of our 2023 cultivation trials. The second shows some of our third generation seeds being bred in our genetics programme.

[Zaks Traders Cafe @ZaksTradersCafe]

Ananda Developments - Operational Update #ANA @AnandaPlc https://t.co/n9ZUAjfFJN

[Ananda Pharma @AnandaPharma]

The MRX Medical website is now LIVE!
We are proud to announce that Ananda subsidiary MRX Medical has now launched its website. Exciting times ahead!
https://t.co/OYQn5NkdT0

[The Medical Cannabis Clinicians Society @ukmccs]

Our fantastic supporters help us in realising our objectives to inform and educate UK prescribers. @AnandaPlc critical role in bolstering our initiatives through their support.

Meet our supporters: https://t.co/YVLthXAlL4

[Dazler @60Toad60]

My money is on @AnandaPlc making all the right moves and perfectly timed!

[Ecoinomy @EcoinomyLtd]

UK Medical Cannabis Clinical Trial Update 🌱

Researchers collected data from over 2,800 patients enrolled on Drug Science’s T21 registry who were prescribed cannabis for a range of indications, including

Chronic pain (53%)
Anxiety disorders (32%) 
PTSD (6%)

[Dazler @60Toad60]

Time to vote for @AnandaPlc if all my followers would be so kind!
https://t.co/oaUdusKMlr

[Ecoinomy @EcoinomyLtd]

The percentage of chronic pain patients who reported the use of opioids reduced from 441 (55.1%) to 177 (22.1%) indicating that over half (59.9%) of those using opioids had stopped all use of these drugs.

[Dazler @60Toad60]

Big news for @AnandaPlc
https://t.co/Jb48pR9I7W

[Ananda Pharma @AnandaPharma]

Ananda is thrilled to have been nominated for the Online Money Awards 'Growth Business of the Year'. This nomination is a testament to our team who have worked so diligently over the last 12 months. To support us and vote, follow the link below.

https://t.co/s3ZBkOwaP9